Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice

Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is a novel approach that permits to modify natural f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kardash, Elena V., Ertuzun, Irina A., Khakimova, Gul'nara R., Kolyadin, Andrey N., Tarasov, Sergey A., Wagner, Stéphanie, Andriambeloson, Emile, Ivashkin, Vladimir T., Epstein, Oleg I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043939/
https://www.ncbi.nlm.nih.gov/pubmed/30013455
http://dx.doi.org/10.1177/1559325818779752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043939/
https://www.ncbi.nlm.nih.gov/pubmed/30013455
http://dx.doi.org/10.1177/1559325818779752

Ejemplares similares